✦ LIBER ✦

Follow-up Study of Patients Treated with Monoclonal Antibody-Drug Conjugate: Report of 77 Cases with Colorectal Cancer

✍ Scribed by Takahashi, Toshio ;Yamaguchi, Toshiharu ;Kitamura, Kazuya ;Noguchi, Akinori ;Honda, Mitsuyo ;Otsuji, Eigo

Book ID: 108579654
Publisher: Wiley (Blackwell Publishing)
Year: 1993
Tongue: English
Weight: 371 KB
Volume: 84
Category: Article
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.1993.tb00188.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical outcome of colorectal cancer pa

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody

✍ Gavin W. L. Denton; Lindy G. Durrant; Jack D. Hardcastle; Eric B. Austin; Herb F 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

## Abstract A human monoclonal anti‐idiotypic antibody (105AD7) has been developed which mimics a colorectal‐tumour‐associated antigen and induces cellular anti‐colorectal tumour immune responses in animals. Thirteen patients with advanced colorectal cancer were immunized with 105AD7 and their surv

Biodistribution of a monoclonal antibody

Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer

✍ K. C. Ballantyne; A. C. Perkins; M. V. Pimm; M. C. Garnett; Jane A. Clegg; N. C. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 547 KB

The monoclonal antibody (MAb) 791T/36 which has previously been shown to localise in colorectal cancer has been conjugated to methotrexate (MTX) for potential use as a chemotherapeutic agent in malignant disease. To examine its biodistribution and tumour localisation, 16 patients with primary colore

Reactivity of purified GP40 antigen with

Reactivity of purified GP40 antigen with antibodies from sera of patients with colorectal cancer: A follow-up study

✍ Yair Gazitt; Z. Bentwich; A. Shani 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 495 KB

## Abstract A glycoprotein antigen (GP40) was previously identified as a major component of immune complexes isolated from sera of patients with Burkitt's lymphoma. Its reactivity with antibodies from sera of patients with various types of cancer was described. In this presentation we describe the

Increased risk of colorectal cancer amon

Increased risk of colorectal cancer among patients with biliary tract inflammation: A 5-year follow-up study

✍ Hsiu-Li Lin; Hsiu-Chen Lin; Ching-Chun Lin; Herng-Ching Lin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 168 KB 👁 2 views

## Abstract The purpose of the study was to investigate the risk of colorectal cancer among patients with biliary tract inflammation (BTI) compared to non‐BTI patients during a 5‐year follow‐up period. The study group comprised 1,613 patients with BTI, among which 32 cases (1.98%) developed colorec

Prognostic factors for patients with col

Prognostic factors for patients with colon or rectal carcinoma treated with resection only: Five-year follow-up report

✍ Takeshi Tominaga; Takashi Sakabe; Yasuo Koyama; Kyoichi Hamano; Masayuki Yasutom 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

## BACKGROUND. The prognostic factors and natural history of recurrence in patients with colorectal carcinoma who underwent curative resection and no other therapy were analyzed. METHODS. The object of analysis was the potentially curative resection only subgroup in the randomized clinical trial (R

Twenty years follow-up of patients with

Twenty years follow-up of patients with inoperable cancer of the prostate (stage c) treated by radiotherapy: Report of a national cooperative study

✍ J.A Del Regato; Alan H Trailins; Donna D Pittman 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 661 KB